Surmodics Inc (SRDX)
32.49
-2.06
(-5.96%)
USD |
NASDAQ |
May 03, 16:00
32.57
+0.08
(+0.25%)
Pre-Market: 20:00
Surmodics Revenue (Quarterly): 30.55M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.55M |
| September 30, 2023 | 27.97M |
| June 30, 2023 | 52.48M |
| March 31, 2023 | 27.20M |
| December 31, 2022 | 24.93M |
| September 30, 2022 | 25.99M |
| June 30, 2022 | 24.85M |
| March 31, 2022 | 26.11M |
| December 31, 2021 | 23.00M |
| September 30, 2021 | 23.97M |
| June 30, 2021 | 23.87M |
| March 31, 2021 | 35.00M |
| December 31, 2020 | 22.30M |
| September 30, 2020 | 22.54M |
| June 30, 2020 | 26.88M |
| March 31, 2020 | 22.82M |
| December 31, 2019 | 22.62M |
| September 30, 2019 | 30.82M |
| June 30, 2019 | 24.34M |
| March 31, 2019 | 22.68M |
| December 31, 2018 | 22.24M |
| September 30, 2018 | 23.04M |
| June 30, 2018 | 22.23M |
| March 31, 2018 | 19.06M |
| December 31, 2017 | 17.01M |
| Date | Value |
|---|---|
| September 30, 2017 | 20.06M |
| June 30, 2017 | 17.79M |
| March 31, 2017 | 17.50M |
| December 31, 2016 | 17.76M |
| September 30, 2016 | 18.15M |
| June 30, 2016 | 19.97M |
| March 31, 2016 | 16.70M |
| December 31, 2015 | 16.54M |
| September 30, 2015 | 17.36M |
| June 30, 2015 | 15.91M |
| March 31, 2015 | 14.42M |
| December 31, 2014 | 14.20M |
| September 30, 2014 | 15.34M |
| June 30, 2014 | 14.62M |
| March 31, 2014 | 13.60M |
| December 31, 2013 | 13.88M |
| September 30, 2013 | 14.30M |
| June 30, 2013 | 14.29M |
| March 31, 2013 | 13.70M |
| December 31, 2012 | 13.85M |
| September 30, 2012 | 13.84M |
| June 30, 2012 | 13.96M |
| March 31, 2012 | 12.21M |
| December 31, 2011 | 11.92M |
| September 30, 2011 | 13.90M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
22.30M
Minimum
Dec 2020
52.48M
Maximum
Jun 2023
27.28M
Average
24.93M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 3.856B |
| ResMed Inc | 1.197B |
| Glaukos Corp | 85.62M |
| Accuray Inc | 107.24M |
| Alphatec Holdings Inc | 137.97M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.786M |
| Total Expenses (Quarterly) | 30.87M |
| EPS Diluted (Quarterly) | -0.06 |
| Enterprise Value | 456.80M |
| Gross Profit Margin (Quarterly) | 42.83% |
| Profit Margin (Quarterly) | -2.57% |
| Earnings Yield | 1.17% |
| Operating Earnings Yield | 2.74% |
| Normalized Earnings Yield | 1.172 |